LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
发明人:
IBRAHIM, ASHRAF, S,SPELLBERG, BRAD, J,EDWARDS, JOHN, E
申请号:
NZ57486207
公开号:
NZ574862A
申请日:
2007.07.13
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
Disclosed is the use of a therapeutically effective amount of at least one iron chelating compound in manufacture of a medicament for treating or preventing mucormycosis, wherein said iron chelating compound is a non-siderophore or non-xenosiderophore relative to mucormycosis. Wherein said iron chelating compound comprises deferiprone or deferasirox. The medicament can also comprise at least one antifungal agent.